HomeGTBP • NASDAQ
add
GT Biopharma Inc
Previous close
$0.75
Day range
$0.73 - $0.81
Year range
$0.63 - $4.10
Market cap
2.84M USD
Avg Volume
300.75K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 1.51M | -61.26% |
Net income | -1.43M | 61.37% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 5.23M | -43.47% |
Total assets | 7.12M | -23.13% |
Total liabilities | 2.31M | -38.63% |
Total equity | 4.82M | — |
Shares outstanding | 3.56M | — |
Price to book | 0.86 | — |
Return on assets | -77.34% | — |
Return on capital | -197.16% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -1.43M | 61.37% |
Cash from operations | -3.01M | 14.76% |
Cash from investing | — | — |
Cash from financing | 5.88M | 97.48% |
Net change in cash | 2.86M | -60.78% |
Free cash flow | -3.88M | -26.15% |
About
Founded
1965
Headquarters
Website
Employees
1
